Quest Diagnostics Reports Strong Q2 Earnings and Raises Guidance
Quest Diagnostics (DGX) shares rose approximately 11% after the diagnostic testing company reported second-quarter earnings that exceeded Wall Street estimates. The firm also raised its full-year guidance for 2026 above consensus expectations.

Tickers: $DGX